Clinical trial Recruiting at 1 site Interventional Ages 18 to 99

Using light therapy to relieve pain from jaw disorders

Official title: Photobiomodulation for Management of Temporomandibular Disorder Pain

Run by University of Florida · NCT05916235 · Data updated 2026-11-12

This study is testing whether light therapy can help relieve pain for people suffering from jaw disorders like temporomandibular disorders (TMD).

Quick facts

Study typeInterventional
Ages18 Years to 99 Years
SexAll
Enrollment130 (estimated)
SponsorUniversity of Florida
Academic / other
Drugs / interventionschemotherapy, radiation
Locations1 site (Gainesville, Florida)
StatusRecruiting
StartedFebruary 8, 2024
Main results expectedOctober 2028
Study endsOctober 2028
Registry record updatedNovember 6, 2026
Trial IDNCT05916235 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are adults aged 18 and older who have been experiencing facial pain related to TMD for at least three months.

Probably not a fit

Patients with active rheumatologic diseases or other significant medical conditions that could interfere with the study may not benefit from this trial.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This clinical trial investigates the use of photobiomodulation (PBM) therapy to alleviate pain associated with temporomandibular disorders (TMD). It employs a double-blind, sham-controlled, randomized design to assess the efficacy of the THOR® laser system in providing pain relief. Participants will be monitored for their pain levels and overall response to the treatment over the course of the study. The aim is to establish a new therapeutic approach for managing TMD pain, which currently lacks FDA-approved treatments.

Why it matters

Potential benefit: If successful, this treatment could provide a non-invasive option for patients suffering from chronic TMD pain.

How similar studies have gone: While photobiomodulation has been FDA-approved for other types of pain, this specific application for TMD is novel and has not been extensively tested in prior studies.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Male or female, aged 18 years and older
* Meets the CATI pre-screening criteria during pre-screening visit \[participant-reported facial pain for at least 3 months and an average pain intensity rating for the week preceding CATI of ≥30 on a numerical rating scale (NRS, 0-100)\].
* Willing to provide signed and dated informed consent
* Willing to to comply with all study procedures and to be available for the duration of the study
* Meets diagnostic criteria for TMD (Masticatory Muscle disorder, 1 A: Myalgia) during Visit 0
* Completes a minimum of 4 of 7 daily symptom diary (DSD) entries prior to Visit 1 (Randomization visit), and the weekly average pain score on this DSD is ≥30 of 100

Exclusion Criteria:

* Active rheumatologic disease
* Has a medical condition, laboratory finding, or physical exam finding (e.g., renal failure or dialysis, uncontrolled diabetes mellitus, or uncontrolled seizures) that precludes participation as determined by the investigator
* Initiated occlusal appliance therapy within 30 days prior to CATI
* Initiated non-pharmacologic therapy, such as acupuncture, biofeedback, and/or TENS within 30 days prior to CATI
* Is in active orthodontic treatment
* Received any injection therapy (e.g., tender or trigger point injections, steroid injections) for the management of pain within 14 days prior to the CATI
* Has a history of facial trauma or orofacial surgery within 6 weeks prior to CATI
* Has a history of psychiatric hospitalization within one year prior to CATI
* Currently pregnant or lactating
* Has a known hypersensitivity to laser therapy
* Currently being treated with chemotherapy or radiation therapy
* Is undergoing treatment with another investigational drug or treatment initiated within 30 days prior to the Screening and Baseline Visit
* Initiated a new daily prescribed or over-the counter medication for the management of pain within 30 days prior to Screening and Baseline Visit.
* Anything that would place the individual at increased risk or preclude the individual's full compliance with or completion of the study as determined by the investigator

Where it's running

  • University of Florida
    Gainesville, Florida, United States
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.